<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: FDA To Review Trasylol Safety - Again</title>
	<atom:link href="http://www.pharmalot.com/2007/08/fda-to-review-safety-of-bayers-trasylol/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2007/08/fda-to-review-safety-of-bayers-trasylol/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 22:01:37 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Tom Lamb</title>
		<link>http://www.pharmalot.com/2007/08/fda-to-review-safety-of-bayers-trasylol/#comment-17589</link>
		<dc:creator>Tom Lamb</dc:creator>
		<pubDate>Fri, 24 Aug 2007 01:21:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/fda-to-review-safety-of-bayers-trasylol/#comment-17589</guid>
		<description>One has to wonder about the timing of this latest FDA Avandia announcement.

As observed at Drug Injury Watch:

"Coincidentally, or ironically, Bayer announced just last week that an outside investigation had concluded these two employees did not intend to mislead the FDA's earlier advisory committee members by withholding that Trasylol side effect information."</description>
		<content:encoded><![CDATA[<p>One has to wonder about the timing of this latest FDA Avandia announcement.</p>
<p>As observed at Drug Injury Watch:</p>
<p>&#8220;Coincidentally, or ironically, Bayer announced just last week that an outside investigation had concluded these two employees did not intend to mislead the FDA&#8217;s earlier advisory committee members by withholding that Trasylol side effect information.&#8221;</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.149 seconds -->

